![]() |
|
|
Vol. 61, Issue 1, 214-221, January 2002
Molecular Nutrition Unit, Institute of Nutritional Science,
Technical University of Munich, Freising-Weihenstephan, Germany (S.T.,
G.K., H.D.); and the Institute of Biochemistry, Department of
Biochemistry/Biotechnology of the Martin-Luther-University
Halle-Wittenberg, Halle, Germany (B.H., K.N.)
The peptide transporter PEPT2, expressed in a variety of tissues,
including kidney, lung, and the central nervous system, mediates the
uphill transport of di- and tripeptides, as well as a variety of
peptidomimetic drugs. To identify the essential molecular features of
substrates that determine affinity and transport by PEPT2, we
synthesized a series of amino acid derivatives as well as modified
dipeptides. Kinetic constants for the interaction of test compounds
with PEPT2 were obtained in a competition assay using Pichia
pastoris yeast cells expressing mammalian PEPT2. The
two-electrode voltage-clamp technique in Xenopus laevis
oocytes was used to assess the substrate's electrogenic transport
properties. Whereas
-amino fatty acids showed no affinity for PEPT2,
the introduction of a single carbonyl group into the backbone increased both affinity and transport currents more than 30-fold.
-Amino fatty
acids, at their amino or carboxyl group coupled to an alanine residue,
allowed us to determine the importance of the spatial position of
functional groups within the molecule. Affinity and transport function
declined by elongating the
-amino acid chain when located in the
N-terminal position, whereas the elongation in the carboxyl terminal
with an N-terminal alanine caused less pronounced effects. The results
clearly establish that a free N terminus, a correctly positioned
backbone carbonyl group, and a carboxylic group that is in a suitable
distance from the intramolecular carbonyl function and the amino
terminal head group are the main features for substrate recognition and
transport by PEPT2. This information provides the framework for a
rational design of peptidomimetic drugs for delivery via PEPT2.
This article has been cited by other articles:
![]() |
D. Weitz, D. Harder, F. Casagrande, D. Fotiadis, P. Obrdlik, B. Kelety, and H. Daniel Functional and Structural Characterization of a Prokaryotic Peptide Transporter with Features Similar to Mammalian PEPT1 J. Biol. Chem., February 2, 2007; 282(5): 2832 - 2839. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Meyer, S. Eskandari, S. Grallath, and D. Rentsch AtGAT1, a High Affinity Transporter for {gamma}-Aminobutyric Acid in Arabidopsis thaliana J. Biol. Chem., March 17, 2006; 281(11): 7197 - 7204. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shen, R. F. Keep, Y. Hu, and D. E. Smith PEPT2 (Slc15a2)-Mediated Unidirectional Transport of Cefadroxil from Cerebrospinal Fluid into Choroid Plexus J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1101 - 1108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Foltz, A. Meyer, S. Theis, H.-U. Demuth, and H. Daniel A Rapid in Vitro Screening for Delivery of Peptide-Derived Peptidase Inhibitors as Potential Drug Candidates via Epithelial Peptide Transporters J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Groneberg, A. Fischer, K. F. Chung, and H. Daniel Molecular Mechanisms of Pulmonary Peptidomimetic Drug and Peptide Transport Am. J. Respir. Cell Mol. Biol., March 1, 2004; 30(3): 251 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kottra, A. Stamfort, and H. Daniel PEPT1 as a Paradigm for Membrane Carriers That Mediate Electrogenic Bidirectional Transport of Anionic, Cationic, and Neutral Substrates J. Biol. Chem., August 30, 2002; 277(36): 32683 - 32691. [Abstract] [Full Text] [PDF] |
||||